+1 212 474 1075
Sandra C. Goldstein is a partner in Cravath's Litigation Department and served as the Firm's Head of Litigation from September 2010 to September 2016. She has a broad litigation practice, with a particular focus on mergers and acquisitions, securities and commercial disputes. Her clients have included Barnes & Noble, Credit Suisse, IBM, Johnson & Johnson, Martin Marietta, Mylan, Novartis, Qualcomm, Starwood Hotels, The Williams Companies and Xerox.
Over the past five years, Ms. Goldstein has represented clients in litigation across the country relating to more than 25 contemplated or hostile transactions with a cumulative value of nearly $500 billion, including: H.J. Heinz ($60 billion merger with Kraft Foods); Cameron International ($15 billion acquisition by Schlumberger); Starwood ($13.3 billion combination with Marriott International); Mylan ($5.6 billion acquisition of Abbott Laboratories' non-U.S. generic drug business); and Symetra ($3.8 billion acquisition by Sumitomo Life). During this time, she secured more than a dozen pre-trial wins. Ms. Goldstein is currently representing The Williams Companies in lawsuits relating to the company's now-terminated $37.7 billion combination with Energy Transfer Equity. She has obtained dismissals in five of these actions. She is also representing Mylan in securities class action litigation relating to its EpiPen product; Qualcomm in securities class action and derivative litigation arising from antitrust investigations concerning the company's patent licensing and modem chipset businesses; Xerox in securities class action litigation related to one of its software products; and Barnes & Noble in a consumer digital privacy class action lawsuit.
Ms. Goldstein has won groundbreaking victories for clients, including summary judgment for Xerox in a 13-year-old $2 billion securities class action (affirmed on appeal); dismissal for First Citizens BancShares of merger litigation that cleared the way for Delaware companies to enact forum-selection bylaws in conjunction with deals, even in anticipation of litigation, an issue of first impression; and a trial victory for Barnes & Noble in activist shareholder litigation in the Delaware Court of Chancery (affirmed on appeal) that provided substantial guidance on "poison pills."
Due to her success, Ms. Goldstein has repeatedly been recognized as a leading lawyer by numerous professional publications, including as a "Litigation Trailblazer" by The National Law Journal and one of the 25 "Most Influential Women in Securities Law" by Law360, which called her a "tough litigator and incisive strategist." She is a three-time recipient of Euromoney Legal Media Group's Americas Women in Business Law Award for "Best in Litigation."
Ms. Goldstein received her B.A. summa cum laude from Barnard College in 1984 and her J.D. from New York University School of Law in 1987. She joined Cravath in 1987 and became a partner in 1994. Ms. Goldstein was the Firm's Litigation Managing Partner from 2005 to 2010.
Last Updated 27th July 2017